Holdings (57)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 7.81539011% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 6.86522464% |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 6.48437526% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 6.32167483% |
| Laurus Labs Ltd. | Healthcare | Equity | 4.6790067% |
| Cipla Ltd. | Healthcare | Equity | 4.19542547% |
| Neuland Laboratories Ltd. | Healthcare | Equity | 3.82380362% |
| Lupin Ltd. | Healthcare | Equity | 3.73159075% |
| Sun Pharmaceutical Industries Ltd. | Healthcare | Futures | 3.07398526% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 2.94370911% |
Returns and rankings
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund Returns | 6.11% | NA% | NA% | NA% |
| Category Average | 0.29% | 21.46% | 15.79% | NA% |
| Rank Within Category | 1.00% | NA% | NA% | NA% |
Expense ratio, exit load and tax
Expense ratio: 0.65%
Inclusive of GST
Exit load
Exit load of 1%, if redeemed within 1 months.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Fund management
Education
Ms. Agrawal has done B.Com and CA.
Experience
Prior to joining WhiteOak Capital Mutual Fund, she has worked with L&T Infrastructure Finance Co. Ltd. and Ernst & Young.
Managed Schemes
WhiteOak Capital Multi Cap Fund Direct Growth
WhiteOak Capital Multi Asset Allocation Fund Direct Growth
WhiteOak Capital Pharma and Healthcare Fund Direct Growth
WhiteOak Capital ELSS Tax Saver Fund Direct Growth
WhiteOak Capital Flexi Cap Fund Direct Growth
WhiteOak Capital Large Cap Fund Direct Growth
WhiteOak Capital Large & Mid Cap Fund Direct Growth
WhiteOak Capital Balanced Advantage Fund Direct Growth
WhiteOak Capital Mid Cap Fund Direct Growth
WhiteOak Capital Banking & Financial Services Fund Direct Growth